Enzymes that hydrolyze adenine nucleotides in patients with ischemic heart disease

Clinica Chimica Acta

Volumn 412, Issue 1-2, 2011, Pages 159-164

  Bagatini, Margarete D ^a   Martins, Caroline C ^a   Gasparetto, Diogo ^b   Spanevello, Roselia M ^a   Becker, Lara V ^a   Rosa, Cintia S ^a   Battisti, Vanessa ^a   Bellé, Luziane ^a   Gonçalves, Jamile F ^a   Schetinger, Maria Rosa C ^a   dos Santos, Romualdo B ^b   Oliveira, Liliane Z ^b   Morsch, Vera Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Hospital Universitario de Santa Maria   (Brazil)

Author keywords

Ischemia; Ischemic heart diseases; Nucleosides; Nucleotides; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADENINE NUCLEOTIDE; ADENOSINE DEAMINASE; AUTOTAXIN; CLOPIDOGREL; ECTO 5' NUCLEOTIDASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE; NUCLEOSIDE; PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS KINETICS; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE KINETICS;

ADENINE NUCLEOTIDES; BLOOD PLATELETS; FEMALE; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION;

EID: 78650513383     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.09.033     Document Type: Article

References (35)

1. Wang X.J., Li Q.P. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem Biophys Res Commun 2007, 359:189-193.
2. Kasper D.N., Braunwald E., Fauci A.S., Hauser S., Longo D.L., Jameson J.L. Harrison medicina interna 2006, 1514-1530. Academic Press, Rio de Janeiro.
3. Pinsky D.J., Broekman M.J., Peschon J.J., et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 2002, 109:1031-1040.
4. Bakker W.W., Poelstra A., Barradas K., Mikhailidis M.A. Platelets and ectonucleotidases. Platelets 1994, 5:121-129.
5. Marcus A.J., Broekman M.J., Drosopoulos J.F.H., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 2003, 1:2497-2509.
6. Soslau G., Youngprapakorn D. A possible dual physiological role of extracellular ATP in modulation of platelet aggregation. Biochim Biophys Acta 1997, 1355:131-140.
7. Rozalski M., Nocun M., Watala C. Adenosine diphosphate receptors on blood platelets - potential new targets for antiplatelet therapy. Acta Biochim Pol 2005, 52:411-415.
8. Borowiec A., Lechward K., Tkacz-Stachowska K., Skladanowski A.C. Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases. Acta Biochim Pol 2006, 53:269-278.
9. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783:673-694.
10. Fürstenau C.R., Trentin D.S., Barreto-Chaves M.L.M., Sarkis J.J.F. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 2006, 17:84-91.
11. Robson S.C., Sevigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2006, 2:409-430.
12. Stefan C., Jansen S., Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 2005, 30:542-550.
13. Colgan S.P., Eltzschig H.K., Eckle T., Thompson L.F. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006, 2:351-360.
14. Blackburn M.R., Kellems R.E. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 2005, 86:1-41.
15. Pilla C., Emanuelli T., Frasetto S.S., et al. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 1996, 7:225-230.
16. Lunkes G.L., Lunkes D., Stefanello F., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 2003, 109:189-194.
17. Chan K., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+-ATPase activity. Anal Biochem 1986, 157:375-380.
18. Guisti G., Galanti B. Colorimetric method. Methods of enzymatic analysis 1984, 315-323. Verlag Chemie, Weinheim. H.U. Bergmeyer (Ed.).
19. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
20. Richter T., Mürdter T.E., Heinkele G., et al. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp Ther 2004, 308:189-197.
21. Tendera M., Wojakowski W. Role of antiplatelet drugs in the prevention of cardiovascular events. Thromb Res 2003, 110:355-359.
22. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:218-254.
23. Schetinger M.R., Morsch V.M., Bonan C., Wyse A. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007, 31:77-98.
24. Bagatini M., Martins C., Battisti V., et al. Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clin Biochem 2008, 41:1181-1185.
25. Maldonado P., Corrêa M., Becker L., et al. Ectonucleotidase Pyrophosphatase/Phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in patients with uterine cervix neoplasia. Clin Biochem 2008, 41:400-406.
26. Duarte M., Loro V., Rocha J., et al. Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes. FEBS 2007, 274:2707-2714.
27. Lunkes G.I., Lunkes D.S., Leal D., et al. Effect of high glucose levels in human platelet NTDase and 5'-nucleotidase activities. Diabetes Res Clin Pract 2008, 8:351-357.
28. Kittel A., Kiss A.L., Müllner N., Matkó I., Sperlágh B. Expression of NTPDase 1 and caveolins in human cardiovascular disease. Histochem Cell Biol 2005, 124:51-59.
29. Kohler D., Eckle T., Faigle M., et al. CD39/ectonucleotidases triphosphate diphosphohydrolase 1 provides myocardial protection during ischemia/reperfusion injury. Circulation 2007, 116:1784-1794.
30. Goding J.W., Grobben B., Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 2003, 1638:1-19.
31. Ely S.W., Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation 1992, 85:893-904.
32. Asakura M., Asanuma H., Kim J., et al. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res 2007, 30:781-787.
33. Bhatt D.L., Topol E.J. Need to test the arterial inflammation hypothesis. Circulation 2002, 106:136-140.
34. Pereillo J.M., Maftouh M., Andrieu A., et al. Structure and sterochemistry of the active metabolite of clopidogrel. Drug Metab Dispos 2002, 30:1288-1295.
35. Herbert J.M. Clopidogrel and antiplatelet therapy. Expert Opin Invest Drug 1994, 3:449-455.